None of these studies was intended to describe adverse effects that might be observed during the test; rather, their aim was to investigate the likely causes of hypoglycemia by measuring related parameters, such as blood glucose, insulin, C-peptide and glucagon-like peptide type 1 (GLP-1). Here, INS is linked to Hypoglycemia.